Barbara Burtness, MD
Yale Cancer Center and Smilow Cancer Hospital recently named Barbara Burtness, MD, chief translational research officer. Additionally, Dr. Burtness will take on the role of associate cancer center director for translational research for Yale Cancer Center.
She will be succeeding Roy S. Herbst, MD, PhD, who provided leadership to the translational research department for the past 10 years. Dr. Burtness has been with Yale Cancer Center since 2014 and is the division chief for head and neck cancers/sarcoma, co-leader of the Developmental Therapeutics Research Program, and interim associate director for diversity, equity, and inclusion.
“Dr. Burtness’ experience, leadership, and mentorship in clinical and translational research will benefit investigators across Yale Cancer Center to build a robust translational research platform for all types of cancer,” the press release said.
Source: Yale Cancer Center, December 2, 2022.